Clinical Trials

AZALEA (Clearside Biomedical)

A phase 3, open-label safety study of suprachoroidal triamcinolone acetonide injectable suspension in patients with non-infectious uveitis.

DOGWOOD (Clearside)

A phase 2, 6 month, randomized, masked, multicenter study to assess the safety and efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the treatment of subjects with macular edema following uveitis.

LUMINA 010906IN (Santen)

A Phase 3, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ìg DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye.

LX211-11 (LUX BIOSCIENCE)

Phase 3 study of the efficacy and safety of voclosporin for non-infectious uveitis.

MAGNOLIA (Clearside Biomedical)

A multicenter, non-interventional extension study of the safety and efficacy of CLS-TA for the treatment of macular edema associated with non-infectious uveitis.

PEACHTREE (Clearside Biomedical)

A 6 month, phase 3, randomized, masked, controlled clinical trial to study the safety and efficacy and safety of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the treatment of subjects with Macular Edema associated with Non-Infectious Uveitis.

SAKURA (SANTEN)

A 2 year Phase 3 active treatment controlled study assessing the efficacy and safety of Sirolimus for the treatment of non-infectious uveitis.

TAHOE (NCRVA and Allergan)

A 6 month Prospective study of the Dexamethasone Intravitreal Implant (Ozurdex) for Uveitic Macular Edema.

VITRASERT

The use of a sustained-release ganciclovir implant to treat Cytomegalovirus Retinitis.